The Biochemical Society welcomes the launch of the Industrial Strategy white paper, published by Department for Business, Energy & Industrial Strategy, which sets out a long-term vision for how Britain can build on its economic strengths, embrace technological change and boost productivity and the earning power of people across the UK.

Commenting on the launch, Professor Sir David Baulcombe, President of the Biochemical Society, said: 

“It is vital for the wider economy, that Britain remains an open and forward-thinking nation for trade and investment following our exit from the European Union. The Biochemical Society is delighted to see that the Industrial Strategy white paper reflects confidence that the life sciences industry can contribute to future development  of the economy and we welcome the announcement of a partnership with the global pharmaceutical firm MSD. This and other initiatives set out in the White Paper will provide almost 1,000 new jobs for the sector and they signify the Government’s commitment to promoting external investment into UK life sciences. 
 
Addressing shortages in STEM skills and supporting lifelong learning will be crucial to meeting the challenges faced by our sector in building a pipeline of future talent. Continued investment in infrastructure will also be key. In order to remain competitive in the global market, the UK must not only invest in new technologies such as genomic medicine, but also ensure that more traditional sectors, such as food and agriculture, continue to be supported.”